Replies to post #1111 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

What is the percentage of patients who failed to complete treatment because of side effects?

In the two main Viekira Pak phase-3 trials, the overall dropout rates—not merely the dropout rates due to side effects—were 0.6% and 1%, respectively (#msg-94169219, #msg-94817670).